KORU Medical Systems Financials - Benzinga

KORU Medical Systems Inc

KRMDNASDAQ

Trade with Public

Trade with Public

$3.34

0.041.21%

Last update: Sep 2, 12:22 PM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

KORU Medical Systems Financials

KORU Medical Systems (KRMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
KORU Medical Systems Narrows FY2026 Sales Guidance from $47.500M-$50.000M to $47.500M-$48.500M vs $48.688M Est

KORU Medical Systems (NASDAQ:KRMD) narrows FY2026 sales outlook from $47.500 million-$50.000 million to $47.500 million-$48.500 million vs $48.688 million estimate.

Benzinga Newsdesk

PRO
KORU Medical Systems Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $12.045M Beat $11.609M Estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 100 percent increase over earnings of $0.01 per share from

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
KORU Medical Systems Affirms FY2026 Sales Guidance of $47.500M-$50.000M vs $48.516M Est

KORU Medical Systems (NASDAQ:KRMD) affirms FY2026 sales outlook from $47.500 million-$50.000 million to $47.500 million-$50.000 million vs $48.516 million estimate.

Benzinga Newsdesk

PRO
KORU Medical Systems Q1 Sales $11.765M Beat $11.284M Estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly sales of $11.765 million which beat the analyst consensus estimate of $11.284 million by 4.26 percent. This is a 22.11 percent increase over sales of $9.635 million

Benzinga Newsdesk

PRO
KORU Medical Systems Sees FY2026 Sales $47.500M-$50.000M vs $48.476M Est

KORU Medical Systems (NASDAQ:KRMD) sees FY2026 sales of $47.500 million-$50.000 million vs $48.476 million analyst estimate.

Benzinga Newsdesk